M V Ramos-Gomez
Overview
Explore the profile of M V Ramos-Gomez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
4
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Aiza-Haddad I, Cisneros-Garza L, Morales-Gutierrez O, Male-Velazquez R, Rizo-Robles M, Alvarado-Reyes R, et al.
Rev Gastroenterol Mex (Engl Ed)
. 2024 Apr;
89(1):144-162.
PMID: 38600006
Coagulation management in the patient with cirrhosis has undergone a significant transformation since the beginning of this century, with the concept of a rebalancing between procoagulant and anticoagulant factors. The...
2.
Contreras-Omana R, Velarde-Ruiz Velasco J, Castro-Narro G, Trujillo-Benavides O, Zamarripa-Dorsey F, Reyes-Dorantes A, et al.
Rev Gastroenterol Mex (Engl Ed)
. 2021 Dec;
87(1):80-88.
PMID: 34866042
The term cholestasis refers to bile acid retention, whether within the hepatocyte or in the bile ducts of any caliber. Biochemically, it is defined by a level of alkaline phosphatase...
3.
Perez-Hernandez J, Arce-Salinas C, Lehmann-Mendoza R, Torre-Delgadillo A, Castro-Narro G, Cerda-Reyes E, et al.
Rev Gastroenterol Mex (Engl Ed)
. 2021 Nov;
87(1):52-58.
PMID: 34774460
Introduction: The sofosbuvir-velpatasvir (SOF/VEL) combination is a direct-acting antiviral therapy that is authorized and available in Mexico, making the performance of a real-world multicenter study that evaluates the sustained virologic...
4.
Higuera-de-la-Tijera F, Castro-Narro G, Velarde-Ruiz Velasco J, Cerda-Reyes E, Moreno-Alcantar R, Aiza-Haddad I, et al.
Rev Gastroenterol Mex (Engl Ed)
. 2021 Sep;
86(4):403-432.
PMID: 34483073
Hepatitis B virus (HBV) infection continues to be a worldwide public health problem. In Mexico, at least three million adults are estimated to have acquired hepatitis B (total hepatitis B...
5.
Higuera-de-la-Tijera F, Castro-Narro G, Velarde-Ruiz Velasco J, Cerda-Reyes E, Moreno-Alcantar R, Aiza-Haddad I, et al.
Rev Gastroenterol Mex (Engl Ed)
. 2021 Aug;
PMID: 34384668
Hepatitis B virus (HBV) infection continues to be a worldwide public health problem. In Mexico, at least three million adults are estimated to have acquired hepatitis B (total hepatitis B...
6.
Perez-Hernandez J, Arce-Salinas C, Lehmann-Mendoza R, Torre-Delgadillo A, Castro-Narro G, Cerda-Reyes E, et al.
Rev Gastroenterol Mex (Engl Ed)
. 2021 Feb;
PMID: 33531165
Introduction: The sofosbuvir-velpatasvir (SOF/VEL) combination is a direct-acting antiviral therapy that is authorized and available in Mexico, making the performance of a real-world multicenter study that evaluates the sustained virologic...
7.
Velarde-Ruiz Velasco J, Higuera-de la Tijera M, Castro-Narro G, Zamarripa-Dorsey F, Abdo-Francis J, Aiza Haddad I, et al.
Rev Gastroenterol Mex (Engl Ed)
. 2020 Jun;
85(3):332-353.
PMID: 32532534
Alcoholic hepatitis is a frequent condition in the Mexican population. It is characterized by acute-on-chronic liver failure, important systemic inflammatory response, and multiple organ failure. The severe variant of the...